The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Cytokine Storms: Understanding COVID-19
Open accessAbstract
The elevated circulating levels of cytokines associated with a variety of infectious and immune-mediated conditions are frequently termed a cytokine storm. Here, we explain the protective functions of cytokines in "ideal" responses; the multi-factorial origins that can drive these responses to become pathological; and how this ultimately leads to vascular damage, immunopathology, and worsening clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with the notion that severe COVID-19 is a cytokine storm syndrome (12–17, 336), the severity of COVID-19 is associated with an increased level of inflammatory cytokines, such as IL-6, granulocyte macrophage colony-stimulating factor (GM-CSF) and TNFα (333, 337).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [336]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
IL-10: The Master Regulator of Immunity to Infection
Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,288
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Thrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,795
Fox, S., Akmatbekov, A., Harbert, J. L., Li, G., Brown, J. Q., & Heide, R. S. V. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30243-5 · Cited by 1,524
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Hemophagocytic Lymphohistiocytosis
Al-Samkari, H. T., & Berliner, N. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043625 · Cited by 510
Min, C.-K., Cheon, S., Ha, N., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J., Inn, K., Kim, J. H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364
Flagged first, then by citations
Cited by
Sorted by citations
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
“Consistent with the notion that severe COVID-19 is a cytokine storm syndrome (12–17, 336 ), SARS-CoV-1 and MERS-CoV activate NF-κ B in a manner dependent on MyD88 through PRRs, such as retinoic acid-inducible gene I protein (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), leading…”
BackgroundVirology, transmission, and pathogenesis of SARS-CoV-2
Çevik, M., Kuppalli, K., Kindrachuk, J., & Peiris, M. J. S. (2020) · BMJ · doi:10.1136/bmj.m3862 · Cited by 781
COVID-19 and the human innate immune system
Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714
“On the other hand, the definition of cytokine storm has expanded to conditions beyond sepsis and, irrespective of absolute cytokine concentrations, to include all inflammatory conditions with elevated circulating cytokines that result in systemic inflammation as well as secondary organ dysfunction (Fajgenbaum and June…”
BackgroundThe signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 618
Galani, I.-E., Rovina, N., Lampropoulou, V., Triantafyllia, V., Manioudaki, M., Pavlos, E., Koukaki, E., Fragkou, P. C., Panou, V., Rapti, V., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00840-x · Cited by 503
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation
Li, S., Zhang, Y., Guan, Z., Li, H., Ye, M., Chen, X., Shen, J., Zhou, Y., Shi, Z.-L., Zhou, P., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00334-0 · Cited by 365
Li, X., Liu, C., Mao, Z., Xiao, M., Wang, L., Qi, S., & Zhou, F. (2020) · Critical Care · doi:10.1186/s13054-020-03374-8 · Cited by 398
Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms
Ahmadian, E., Khatibi, S. M. H., Soofiyani, S. R., Abediazar, S., Shoja, M. M., Ardalan, M., & Vahed, S. Z. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2176 · Cited by 366
Meng, F., Xu, R., Wang, S., Xu, Z., Zhang, C., Li, Y., Yang, T., Shi, L., Fu, J., Jiang, T., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00286-5 · Cited by 322
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Afrin, L. B., Weinstock, L. B., & Molderings, G. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.016 · Cited by 319
Xiao, N., Nie, M., Pang, H., Wang, B., Hu, J., Meng, X., Li, K., Ran, X., Long, Q., Deng, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21907-9 · Cited by 309
Shi, L., Huang, H., Lu, X.-C., Yan, X., Jiang, X., Xu, R., Wang, S., Zhang, C., Yuan, X., Xu, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00488-5 · Cited by 282
Hoepel, W., Chen, H., Geyer, C. E., Allahverdiyeva, S., Manz, X. D., de Taeye, S. W., Aman, J., Mes, L., Steenhuis, M., Griffith, G. R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8654 · Cited by 282
COVID-19 and Cancer: Current Challenges and Perspectives
Bakouny, Z., Hawley, J. E., Choueiri, T. K., Peters, S., Rini, B. I., Warner, J. L., & Painter, C. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.018 · Cited by 276
Bergamaschi, C., Terpos, E., Rosati, M., Angel, M., Bear, J., Stellas, D., Karaliota, S., Apostolakou, F., Bagratuni, T., Patseas, D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109504 · Cited by 236
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
Aid, M., Busman-Sahay, K., Vidal, S. J., Maliga, Z., Bondoc, S., Starke, C., Terry, M., Jacobson, C. A., Wrijil, L., Ducat, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.005 · Cited by 215
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
Mills, R. J., Humphrey, S. J., Fortuna, P. R. J., Lor, M., Foster, S. R., Quaife-Ryan, G. A., Johnston, R. L., Dumenil, T. D., Bishop, C., Rudraraju, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.026 · Cited by 229
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Garred, P., Tenner, A. J., & Mollnes, T. E. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000072 · Cited by 219
Initiative, N. H. U. B., Julkunen, H., Cichońska, A., Slagboom, P. E., & Würtz, P. (2021) · eLife · doi:10.7554/elife.63033 · Cited by 200
Li, F., Li, J., Wang, P., Yang, N., Huang, J., Ou, J., Xu, T., Zhao, X., Liu, T., Huang, X., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166260 · Cited by 211
Thépaut, M., Luczkowiak, J., Vivès, C., Labiod, N., Bally, I., Lasala, F., Grimoire, Y., Fenel, D., Sattin, S., Thielens, N. M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009576 · Cited by 222
Viral Respiratory Pathogens and Lung Injury
Clementi, N., Ghosh, S., Santis, M. D., Castelli, M., Criscuolo, E., Zanoni, I., Clementi, M., & Mancini, N. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00103-20 · Cited by 202
The humoral response and antibodies against SARS-CoV-2 infection
Qi, H., Liu, B., Wang, X., & Zhang, L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01248-5 · Cited by 195
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
Patterson, B. K., Guevara-Coto, J. A., Yogendra, R., Francisco, E. B., Long, E., Pise, A., Rodrigues, H., Parikh, P., Mora, J., & Mora-Rodríguez, R. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700782 · Cited by 192
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19
Scozzi, D., Cano, M., Ma, L., Zhou, D., Zhu, J. H., O’Halloran, J. A., Goss, C. W., Rauseo, A. M., Liu, Z., Sahu, S. K., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143299 · Cited by 181
IL-13 is a driver of COVID-19 severity
Donlan, A. N., Sutherland, T. E., Marie, C. S., Preißner, S., Bradley, B. T., Carpenter, R. M., Sturek, J. M., Ma, J. Z., Moreau, G. B., Donowitz, J. R., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150107 · Cited by 186
Controlling Cytokine Storm Is Vital in COVID-19
Tang, L., Yin, Z., Hu, Y., & Mei, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570993 · Cited by 183
SARS-CoV-2, the autoimmune virus
Halpert, G., & Shoenfeld, Y. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102695 · Cited by 184
Sun, Z., Song, Z., Liu, C., Tan, S., Lin, S., Zhu, J., Dai, F., Gao, J., She, J.-L., Mei, Z., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02212-0 · Cited by 173
Li, J., Xie, L., Li, B., Yin, C., Wang, G., Sang, W., Li, W., Tian, H., Zhang, Z., Zhang, X., et al. (2021) · Advanced Materials · doi:10.1002/adma.202008481 · Cited by 169
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
Bleve, A., Motta, F., Durante, B., Pandolfo, C., Selmi, C., & Sica, A. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08909-7 · Cited by 185
Ryabkova, V. A., Churilov, L. P., & Shoenfeld, Y. (2021) · Clinical Immunology · doi:10.1016/j.clim.2020.108652 · Cited by 164
Theobald, S. J., Simonis, A., Georgomanolis, T., Kreer, C., Zehner, M., Eisfeld, H. S., Albert, M., Chhen, J., Motameny, S., Erger, F., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114150 · Cited by 172
Bunders, M. J., & Altfeld, M. A. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.003 · Cited by 167
Innate and adaptive immune responses against coronavirus
Hosseini, A., Hashemi, V., Shomali, N., Asghari, F., Gharibi, T., Akbari, M., Gholizadeh, S., & Jafari, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110859 · Cited by 162
Zhao, Y., Kilian, C., Turner, J., Bosurgi, L., Roedl, K., Bartsch, P., Gnirck, A.-C., Cortesi, F., Schultheiß, C., Hellmig, M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf6692 · Cited by 157
Saichi, M., Ladjemi, M. Z., Korniotis, S., Rousseau, C., Hamou, Z. A., Massenet-Regad, L., Amblard, E., Noël, F., Marie, Y., Bouteiller, D., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00681-2 · Cited by 159
de Melo, A. K. G., Milby, K. M., Caparroz, A. L. M. A., Pinto, A. C. P. N., Santos, R. R. P., da Rocha, A. P., Ferreira, G. A., de Souza, V. A., Valadares, L. D. D. A., Vieira, R. M. R. D. A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253894 · Cited by 159
Is IL-6 a key cytokine target for therapy in COVID-19?
Jones, S. A., & Hunter, C. A. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00553-8 · Cited by 139
Self-citationGlycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment
Zhao, Z., Xiao, Y., Xu, L., Liu, Y., Jiang, G., Wang, W., Li, B., Zhu, T., Tan, Q., Tang, L., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c02755 · Cited by 143
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Lee, W., Ahn, J. H., Park, H. H., Kim, H. N., Kim, H., Yoo, Y., Shin, H., Hong, K. S., Jang, J. G., Park, C. G., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00292-7 · Cited by 141
A Wearable Tele-Health System towards Monitoring COVID-19 and Chronic Diseases
Jiang, W., Majumder, S., Kumar, S., Subramaniam, S., Li, X., Khedri, R., Mondal, T. K., Abolghasemian, M., Satia, I., & Deen, M. J. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2021.3069815 · Cited by 140
Xu, H., Li, S., Liu, J., Cheng, J., Kang, L., Li, W., Zhong, Y., Wei, C., Fu, L., Qi, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2301775120 · Cited by 136
Littera, R., Campagna, M., Deidda, S., Angioni, G., Cipri, S., Melis, M., Firinu, D., Santus, S., Lai, A., Porcella, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.605688 · Cited by 136
Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19
Liu, Y., Lv, J., Liu, J., Li, M., Xie, J., Lv, Q., Deng, W., Zhou, N., Zhou, Y., Song, J., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00435-z · Cited by 130
Cardiovascular impact of COVID-19 with a focus on children: A systematic review
Rodríguez‐González, M., Castellano‐Martínez, A., Cascales-Poyatos, H. M., & Pérez-Reviriego, Á. A. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i21.5250 · Cited by 139
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway
Lin, X., Fu, B., Yin, S., Li, Z., Liu, H., Zhang, H., Xing, N., Wang, Y., Xue, W., Xiong, Y., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102293 · Cited by 128
Zeng, J., Xie, X., Feng, X., Xu, L., Han, J.-B., Yu, D., Zou, Q., Liu, Q., Li, X., Ma, G., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103803 · Cited by 130
The Role of Ferritin in Health and Disease: Recent Advances and Understandings
Kotla, N. K., Dutta, P., Parimi, S., & Das, N. K. (2022) · Metabolites · doi:10.3390/metabo12070609 · Cited by 141
Fodor, A., Tiperciuc, B., Login, C., Orasan, O. H., Lazăr, A.-L., Buchman, C., Hanghicel, P., Sitar-Tăut, A., Suharoschi, R., Vulturar, R., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8671713 · Cited by 127
Hopfer, H., Herzig, M. C., Gosert, R., Menter, T., Hench, J., Tzankov, A., Hirsch, H. H., & Miller, S. (2020) · Histopathology · doi:10.1111/his.14264 · Cited by 113
Al-Hatamleh, M. A. I., Hatmal, M. M., Sattar, K., Ahmad, S., Mustafa, M. Z., Bittencourt, M. D. C., & Mohamud, R. (2020) · Molecules · doi:10.3390/molecules25215017 · Cited by 120
Migliorini, F., Torsiello, E., Spiezia, F., Oliva, F., Tingart, M., & Maffulli, N. (2021) · European journal of medical research · doi:10.1186/s40001-021-00563-1 · Cited by 114
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response
Zhao, Y., Sui, L., Wu, P., Wang, W., Wang, Z., Yu, Y., Hou, Z., Tan, G., Liu, Q., & Wang, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00742-w · Cited by 114
Monocyte activation in systemic Covid-19 infection: Assay and rationale
Martínez, F. O., Combes, T., Orsenigo, F., & Gordon, S. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102964 · Cited by 111
Shohan, M., Nashibi, R., Mahmoudian‐Sani, M., Abolnezhadian, F., Ghafourian, M., Alavi, S. M., Sharhani, A., & Khodadadi, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174615 · Cited by 114
Polymeric particle-based therapies for acute inflammatory diseases
Brannon, E. R., Guevara, M. V., Pacifici, N. J., Lee, J. K., Lewis, J. S., & Eniola‐Adefeso, O. (2022) · Nature Reviews Materials · doi:10.1038/s41578-022-00458-5 · Cited by 103
Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases
Tang, X., Ji, T.-T., Dong, J.-R., Feng, H., Chen, F.-Q., Chen, X., Zhao, H., Chen, D., & Ma, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313009 · Cited by 108
Kim, E.-H., Nguyen, Q. T., Casel, M. A. B., Rollon, R., Kim, S., Kim, Y., Yu, K.-M., Jang, S., Yang, J., Poo, H., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01873-21 · Cited by 89
Guo, Y., Chen, X., & Gong, P. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.05.139 · Cited by 90
Ma, A., Zhang, L., Ye, X., Chen, J., Yu, J., Zhuang, L., Weng, C., Petersen, F., Wang, Z., & Yu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626235 · Cited by 89
COVID-19: Inflammatory Profile
Wang, Y., & Perlman, S. M. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-012417 · Cited by 93
Pang, Y., Wu, L., Tang, C. C., Wang, H., & Wei, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.832750 · Cited by 87
Haljasmägi, L., Salumets, A., Rumm, A. P., Jürgenson, M., Krassohhina, E., Remm, A., Sein, H., Kareinen, L., Vapalahti, O., Sironen, T. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77525-w · Cited by 86
Wang, L., Balmat, T. J., Antonia, A. L., Constantine, F. J., Henao, R., Burke, T. W., Ingham, A., McClain, M. T., Tsalik, E. L., Ko, E. R., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00904-z · Cited by 85
Tanaçan, A., Yazıhan, N., Erol, S. A., Anuk, A. T., Yetişkin, F. D. Y., Biriken, D., Ozgu-Erdinc, A. S., Keskin, H. L., Tekın, Ö. M., & Şahın, D. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155431 · Cited by 85
Jia, J., Wang, M., Meng, J., Ma, Y., Wang, Y., Miao, N., Teng, J., Zhu, D., Shi, H., Sun, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34560-7 · Cited by 85
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
Gupta, A., Kashte, S., Gupta, M., Rodriguez, H. C., Gautam, S. S., & Kadam, S. S. (2020) · Human Cell · doi:10.1007/s13577-020-00407-w · Cited by 82
Tang, J., Ravichandran, S., Lee, Y., Grubbs, G., Coyle, E. M., Klenow, L., Genser, H., Golding, H., & Khurana, S. (2021) · Nature Communications · doi:10.1038/s41467-021-21463-2 · Cited by 81
Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS)
Sikora, J. P., Karawani, J., & Sobczak, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713469 · Cited by 98
Understanding the pathophysiological changes via untargeted metabolomics in COVID‐19 patients
Doğan, H. O., Şenol, O., Bolat, S., Yıldız, Ş. N., Büyüktuna, S. A., Sarıismailoğlu, R., Doğan, K., Hasbek, M., & Hekim, S. N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26716 · Cited by 78
Co‐infection of influenza A virus and SARS‐CoV‐2: A retrospective cohort study
Cheng, Y., Ma, J., Wang, H., Wang, X., Hu, Z., Li, H., Zhang, H., & Liu, X. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26817 · Cited by 77
Caterino, M., Costanzo, M., Fedele, R., Cevenini, A., Gelzo, M., Minno, A. D., Andolfo, I., Capasso, M., Russo, R., Annunziata, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179548 · Cited by 77
Li, J., Liu, R., Cui, R., Feng, J., Jin, Y., Yu, Y., Chen, X., & Xu, R. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-2134 · Cited by 76
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Wang, L., Wu, Y. L., Yao, S., Ge, H., Zhu, Y., Chen, K., Chen, W., Zhang, Y., Zhu, W. J., Wang, H., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00735-z · Cited by 77
Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers
Zafer, M. M., El‐Mahallawy, H. A., & Ashour, H. M. (2021) · Microorganisms · doi:10.3390/microorganisms9010159 · Cited by 74
Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications
Habashi, N. M., Camporota, L., Gatto, L. A., & Nieman, G. F. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00742.2020 · Cited by 73
COVID‐19: Neuroimaging Features of a Pandemic
Ladopoulos, T., Zand, R., Shahjouei, S., Chang, J. J., Motte, J., James, J. C., Katsanos, A. H., Kerro, A., Farahmand, G., Far, A. V., et al. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12819 · Cited by 71
Calabrese, M., Garofano, M., Palumbo, R., Pietro, P. D., Izzo, C., Damato, A., Venturini, E., Iesu, S., Virtuoso, N., Strianese, A., et al. (2021) · Life · doi:10.3390/life11030259 · Cited by 76
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Jiang, Y., Zhao, T., Zhou, X., Yu, X., Gutiérrez‐Castrellón, P., & Ma, X. (2022) · MedComm · doi:10.1002/mco2.154 · Cited by 77
Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2
Stephensen, C. B., & Lietz, G. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521000246 · Cited by 66
Argano, C., Bocchio, R. M., Natoli, G., Scibetta, S., Monaco, M. L., & Corrao, S. (2023) · Pharmaceuticals · doi:10.3390/ph16010130 · Cited by 67
RetractedGawish, R., Starkl, P. M., Pimenov, L., Hladik, A., Lakovits, K., Oberndorfer, F., Cronin, S. J., Ohradanova‐Repic, A., Wirnsberger, G., Agerer, B., et al. (2022) · eLife · doi:10.7554/elife.74623 · Cited by 61
Host Recovery from Respiratory Viral Infection
Wei, X., Narasimhan, H., Zhu, B., & Sun, J. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-040450 · Cited by 63
The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm
Zimecki, M., Actor, J. K., & Kruzel, M. L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107571 · Cited by 61
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
Faour, W. H., Choaib, A., Issa, E., Choueiry, F. E., Shbaklo, K., Alhajj, M., Sawaya, R. T., Harhous, Z., Alefishat, E. A., & Nader, M. (2021) · Inflammation Research · doi:10.1007/s00011-021-01520-8 · Cited by 63
Guo, M., Shang, S., Li, M., Cai, G., Li, P., Chen, X., & Li, Q. (2024) · Medical Review · doi:10.1515/mr-2024-0013 · Cited by 64
Helminth coinfection and COVID-19: An alternate hypothesis
Hays, R., Pierce, D. R., Giacomin, P., Loukas, A. C., Bourke, P., & McDermott, R. A. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008628 · Cited by 60
Infante, M., Buoso, A., Pieri, M., Lupisella, S., Nuccetelli, M., Bernardini, S., Fabbri, A., Iannetta, M., Andreoni, M., Colizzi, V., et al. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1877580 · Cited by 59
Zhang, S., Amahong, K., Zhang, C., Li, F., Gao, J., Qiu, Y., & Zhu, F. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab397 · Cited by 58
Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality
Sakuraba, A., Haider, H., & Sato, T. (2020) · Viruses · doi:10.3390/v12111333 · Cited by 59
Hussain, M. S., Sharma, P., Dhanjal, D. S., Khurana, N., Vyas, M., Sharma, N., Mehta, M., Tambuwala, M. M., Satija, S., Sohal, S. S., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109637 · Cited by 60
Mohiuddin, M., & Kasahara, K. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106716 · Cited by 57
Comprehensive Landscape of Heparin Therapy for COVID-19
Shi, C., Wu, T., Li, J.-P., Sullivan, M. A., Wang, C., Wang, H., Deng, B., & Zhang, Y. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117232 · Cited by 59
Ye, Z., Yuan, S., Chan, J. F., Zhang, J., Yu, C.-Y., Ong, C. P., Yang, D., Chan, C. C.-Y., Tang, K., Cao, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1885998 · Cited by 55
Programmed cell death: the pathways to severe COVID-19?
Bader, S. M., Cooney, J. P., Pellegrini, M., & Doerflinger, M. (2022) · Biochemical Journal · doi:10.1042/bcj20210602 · Cited by 55
Biji, A., Khatun, O., Swaraj, S., Narayan, R., Rajmani, R. S., Sardar, R., Satish, D., Mehta, S., Bindhu, H., Jeevan, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103525 · Cited by 54
Current Understanding of the Neutrophil Transcriptome in Health and Disease
Garratt, L. W. (2021) · Cells · doi:10.3390/cells10092406 · Cited by 53
Early prediction of COVID‐19 severity using extracellular vesicle COPB2
Fujita, Y., Hoshina, T., Matsuzaki, J., Yoshioka, Y., Kadota, T., Hosaka, Y., Fujimoto, S., Kawamoto, H., Watanabe, N., Sawaki, K., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12092 · Cited by 56
Balagholi, S., Dabbaghi, R., Eshghi, P., Mousavi, S. A., Heshmati, F., & Mohammadi, S. (2020) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2020.102993 · Cited by 51
Metadata
- Authors
- Mangalmurti, N., & Hunter, C. A.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Hunter, Christopher A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 53
- Issue
- 1
- Pages
- 19-25
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC7321048
- OpenAlex
- W3037676127
- Cited by
- 698
- References
- 15
- Citations by year
- 2026: 17 · 2025: 49 · 2024: 64 · 2023: 111 · 2022: 159 · 2021: 228 · 2020: 70
- FWCI
- 18.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- cytokine storm, COVID-19 pandemic, cytokines, SARS-CoV-2, immunopathology, vascular injury, hyperinflammation, clinical outcomes, protective immune response
- MeSH terms
- Betacoronavirus, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Inflammation, Pneumonia, Viral, Cytokines, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
